A detailed history of William Von Mueffling (Cantillon Capital Management LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Cantillon Capital Management LLC holds 1,392,262 shares of ZTS stock, worth $244 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
1,392,262
Previous 1,420,220 1.97%
Holding current value
$244 Million
Previous $280 Million 15.96%
% of portfolio
1.51%
Previous 1.9%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$165.67 - $199.94 $4.63 Million - $5.59 Million
-27,958 Reduced 1.97%
1,392,262 $236 Million
Q4 2023

Feb 07, 2024

SELL
$151.44 - $200.09 $5.2 Million - $6.87 Million
-34,345 Reduced 2.36%
1,420,220 $280 Million
Q3 2023

Nov 06, 2023

SELL
$167.14 - $192.77 $952,865 - $1.1 Million
-5,701 Reduced 0.39%
1,454,565 $253 Million
Q2 2023

Aug 09, 2023

SELL
$160.94 - $186.23 $52.9 Million - $61.2 Million
-328,424 Reduced 18.36%
1,460,266 $251 Million
Q1 2023

May 04, 2023

SELL
$145.48 - $175.02 $4.13 Million - $4.97 Million
-28,371 Reduced 1.56%
1,788,690 $298 Million
Q4 2022

Feb 06, 2023

SELL
$131.14 - $157.47 $5.34 Million - $6.41 Million
-40,690 Reduced 2.19%
1,817,061 $266 Million
Q3 2022

Nov 03, 2022

SELL
$148.29 - $182.55 $2.01 Million - $2.48 Million
-13,566 Reduced 0.72%
1,857,751 $275 Million
Q2 2022

Aug 03, 2022

SELL
$155.97 - $200.09 $1.18 Million - $1.52 Million
-7,573 Reduced 0.4%
1,871,317 $322 Million
Q1 2022

May 03, 2022

BUY
$181.39 - $234.03 $9.59 Million - $12.4 Million
52,845 Added 2.89%
1,878,890 $354 Million
Q4 2021

Jan 27, 2022

SELL
$193.69 - $247.03 $73.7 Million - $94 Million
-380,519 Reduced 17.24%
1,826,045 $446 Million
Q3 2021

Oct 26, 2021

SELL
$189.29 - $209.69 $7.04 Million - $7.8 Million
-37,203 Reduced 1.66%
2,206,564 $428 Million
Q2 2021

Jul 27, 2021

SELL
$155.9 - $187.99 $21.4 Million - $25.8 Million
-137,431 Reduced 5.77%
2,243,767 $418 Million
Q1 2021

May 03, 2021

SELL
$144.0 - $169.39 $76.2 Million - $89.6 Million
-529,089 Reduced 18.18%
2,381,198 $375 Million
Q4 2020

Feb 03, 2021

SELL
$157.07 - $174.35 $1.47 Million - $1.64 Million
-9,381 Reduced 0.32%
2,910,287 $482 Million
Q3 2020

Oct 30, 2020

SELL
$137.1 - $165.37 $4.62 Million - $5.58 Million
-33,724 Reduced 1.14%
2,919,668 $483 Million
Q2 2020

Jul 31, 2020

BUY
$111.92 - $142.53 $3.29 Million - $4.19 Million
29,427 Added 1.01%
2,953,392 $405 Million
Q1 2020

Apr 30, 2020

SELL
$92.66 - $144.94 $38.7 Million - $60.5 Million
-417,155 Reduced 12.49%
2,923,965 $344 Million
Q4 2019

Feb 07, 2020

SELL
$116.25 - $133.25 $40.1 Million - $46 Million
-345,352 Reduced 9.37%
3,341,120 $442 Million
Q3 2019

Nov 04, 2019

SELL
$112.57 - $128.43 $2.46 Million - $2.8 Million
-21,828 Reduced 0.59%
3,686,472 $459 Million
Q2 2019

Jul 26, 2019

SELL
$97.98 - $114.28 $7.36 Million - $8.59 Million
-75,125 Reduced 1.99%
3,708,300 $421 Million
Q1 2019

May 01, 2019

SELL
$81.56 - $100.67 $1.55 Million - $1.91 Million
-18,996 Reduced 0.5%
3,783,425 $381 Million
Q4 2018

Feb 05, 2019

BUY
$79.28 - $95.27 $2.1 Million - $2.52 Million
26,430 Added 0.7%
3,802,421 $325 Million
Q3 2018

Nov 09, 2018

SELL
$83.5 - $93.23 $20.6 Million - $23 Million
-247,129 Reduced 6.14%
3,775,991 $346 Million
Q2 2018

Aug 07, 2018

SELL
$79.9 - $89.2 $8.91 Million - $9.95 Million
-111,557 Reduced 2.7%
4,023,120 $343 Million
Q1 2018

May 08, 2018

SELL
$71.51 - $84.69 $62.6 Million - $74.1 Million
-875,044 Reduced 17.47%
4,134,677 $345 Million
Q4 2017

Feb 12, 2018

SELL
$63.24 - $72.8 $22 Million - $25.3 Million
-347,457 Reduced 6.49%
5,009,721 $361 Million
Q3 2017

Nov 13, 2017

SELL
$59.73 - $65.4 $9.34 Million - $10.2 Million
-156,387 Reduced 2.84%
5,357,178 $342 Million
Q2 2017

Aug 07, 2017

BUY
N/A
5,513,565
5,513,565 $344 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track William Von Mueffling's Portfolio

Track William Von Mueffling Portfolio

Follow William Von Mueffling (Cantillon Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cantillon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cantillon Capital Management LLC and William Von Mueffling with notifications on news.